Bone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseWhole-Body IrradiationTissue DonorsTransplantation, AutologousAcademies and InstitutesTransplantation ConditioningHistocompatibilityLeukemiaTransplantation ChimeraHistocompatibility TestingGraft SurvivalBone and BonesRadiation ChimeraAnemia, AplasticHematopoietic Stem Cell TransplantationHematopoietic Stem CellsHost vs Graft ReactionLiver TransplantationBone Marrow PurgingLymphocyte DepletionBone Marrow DiseasesBusulfanPediatricsLeukocyte TransfusionMice, Inbred C57BLSocieties, MedicalRecurrenceGraft RejectionBone Marrow ExaminationCyclophosphamideTransplantation, IsogeneicImmunosuppressive AgentsHematopoiesisTreatment OutcomeKidney TransplantationBone Marrow NeoplasmsHLA AntigensT-LymphocytesTime FactorsCombined Modality TherapyLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSurvival AnalysisRemission InductionHematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseAcute DiseaseLeukemia, MyeloidTransplantation ImmunologyColony-Forming Units AssayGraft vs Host ReactionBone RemodelingRetrospective StudiesImmunosuppressionUnited StatesStem Cell TransplantationLiving DonorsLymphoma, Non-HodgkinHeart TransplantationChimeraMyelodysplastic SyndromesSevere Combined ImmunodeficiencyNeurologyCell DifferentiationAfrican AmericansHematologic DiseasesFollow-Up StudiesLung TransplantationActuarial AnalysisCyclosporinePancytopeniaLymphocyte TransfusionBone DensityBlood DonorsSpleenAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyLeukocyte CountNational Academy of Sciences (U.S.)Flow CytometryOrgan TransplantationCarmustineCells, CulturedGranulocyte Colony-Stimulating FactorSurvival RateGraft vs Tumor EffectMice, Inbred BALB CCytarabineCytomegalovirus InfectionsMultiple MyelomaGraft vs Leukemia EffectAntigens, CD34Bone ResorptionMelphalanDisease-Free Survival